• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美沙酮药物滥用者和共病物质使用障碍者的医疗补助治疗利用情况。

Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.

机构信息

IBM Watson Health, 5425 Hollister Avenue, Suite 140, Santa Barbara, CA 93111, USA.

IBM Watson Health, 75 Binney Street, Cambridge, MA 02142, USA.

出版信息

Drug Alcohol Depend. 2020 Dec 1;217:108261. doi: 10.1016/j.drugalcdep.2020.108261. Epub 2020 Aug 28.

DOI:10.1016/j.drugalcdep.2020.108261
PMID:32979735
Abstract

BACKGROUND

Multiple substance use is common among adults who misuse opioids. Adverse consequences of drugs are more severe among multisubstance users than among single drug users. This study sought to determine whether adults with opioid use disorder (OUD) and at least one other substance use disorder (SUD) are less likely than adults with OUD only to receive certain services.

METHODS

We conducted a retrospective longitudinal study using the IBM® MarketScan® Multi-State Medicaid Database. We used logistic regression to measure associations between clinical characteristics and service utilization. The sample included non-Medicare-eligible adults aged 18-64 years with at least one claim in 2016 with a primary diagnosis of OUD who were continuously enrolled in Medicaid in 2016 and 2017.

RESULTS

Of the 58,745 Medicaid enrollees with an initial OUD diagnosis in 2016, 29,267 had one or more additional SUD diagnoses. In the year following diagnosis, these adults were less likely than adults with OUD only to receive OUD medication treatment (OR = 0.88, p < .0001). This was true for all specifically diagnosed co-occurring SUDS. Adults with OUD and a co-occurring SUD, however, were more likely than those with OUD only to use any type of high-intensity services.

CONCLUSIONS

Adults with OUD and at least one co-occurring SUD received more intensive services, which may reflect severity and lack of OUD medication treatment before misuse escalation. Programs should account for barriers to connecting these individuals to appropriate OUD treatment.

摘要

背景

在滥用阿片类药物的成年人中,多种物质使用很常见。与单一药物使用者相比,多种物质使用者的药物不良后果更为严重。本研究旨在确定是否患有阿片类药物使用障碍(OUD)且至少有另一种物质使用障碍(SUD)的成年人比仅患有 OUD 的成年人更不可能接受某些服务。

方法

我们使用 IBM® MarketScan®多州医疗补助数据库进行了回顾性纵向研究。我们使用逻辑回归来衡量临床特征与服务利用之间的关联。该样本包括非 Medicare 合格的 18-64 岁成年人,他们在 2016 年至少有一次 OUD 的主要诊断,并在 2016 年和 2017 年连续参加医疗补助计划。

结果

在 2016 年有初始 OUD 诊断的 58745 名医疗补助参保者中,有 29267 人有一个或多个其他 SUD 诊断。在诊断后的一年中,与仅患有 OUD 的成年人相比,这些成年人接受 OUD 药物治疗的可能性较低(OR = 0.88,p <.0001)。对于所有具体诊断的共病 SUD 都是如此。然而,患有 OUD 和共病 SUD 的成年人比仅患有 OUD 的成年人更有可能使用任何类型的高强度服务。

结论

患有 OUD 且至少有一个共病 SUD 的成年人接受了更密集的服务,这可能反映出滥用升级前的严重程度和缺乏 OUD 药物治疗。计划应考虑到将这些人与适当的 OUD 治疗联系起来的障碍。

相似文献

1
Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.美沙酮药物滥用者和共病物质使用障碍者的医疗补助治疗利用情况。
Drug Alcohol Depend. 2020 Dec 1;217:108261. doi: 10.1016/j.drugalcdep.2020.108261. Epub 2020 Aug 28.
2
Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.成年医疗补助受保人中有阿片类药物使用障碍和同时存在物质使用障碍者的不良事件。
Drug Alcohol Depend. 2021 Apr 1;221:108555. doi: 10.1016/j.drugalcdep.2021.108555. Epub 2021 Jan 29.
3
Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.多物质使用障碍与医疗补助受益的阿片类药物使用障碍患者的治疗质量之间的关联。
J Subst Abuse Treat. 2023 Jan;144:108921. doi: 10.1016/j.jsat.2022.108921. Epub 2022 Oct 27.
4
The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.初级保健在改善农村医疗补助计划参保者阿片类药物使用障碍患者获得药物辅助治疗方面的作用。
J Gen Intern Med. 2019 Jun;34(6):936-943. doi: 10.1007/s11606-019-04943-6. Epub 2019 Mar 18.
5
Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.美国 11 个州的医疗补助受助人在 2014-2018 年期间使用药物治疗阿片类药物使用障碍的情况。
JAMA. 2021 Jul 13;326(2):154-164. doi: 10.1001/jama.2021.7374.
6
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.美国退伍军人事务部的多药物使用与阿片类药物使用障碍治疗的关系。
Addiction. 2021 Jan;116(1):96-104. doi: 10.1111/add.15116. Epub 2020 Jul 7.
7
Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.美国多州医疗补助索赔中的阿片类药物使用障碍生殖年龄妇女布比卡因和美沙酮利用中的种族和民族不平等现象分析。
J Gen Intern Med. 2023 Dec;38(16):3499-3508. doi: 10.1007/s11606-023-08306-0. Epub 2023 Jul 12.
8
Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.阿片类药物使用障碍和处方阿片类药物方案:来自商业和医疗补助索赔数据的证据,2005-2015 年。
J Med Toxicol. 2019 Jul;15(3):156-168. doi: 10.1007/s13181-019-00715-0. Epub 2019 May 31.
9
Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.多州医疗补助参保者样本中阿片类药物使用障碍患者丁丙诺啡治疗中断的风险因素。
J Subst Abuse Treat. 2018 Dec;95:9-17. doi: 10.1016/j.jsat.2018.09.001. Epub 2018 Sep 7.
10
Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.俄勒冈州 2014 年扩大医疗补助计划后,处方类阿片的使用模式、使用障碍诊断和成瘾治疗的接受情况。
Addiction. 2019 Oct;114(10):1775-1784. doi: 10.1111/add.14667. Epub 2019 Jun 30.

引用本文的文献

1
Race and Ethnicity and Diffusion of Telemedicine in Medicaid for Schizophrenia Care After Onset of the COVID-19 Pandemic.新冠疫情爆发后,种族和族裔与远程医疗在医疗补助计划中用于精神分裂症护理的推广情况
JAMA Netw Open. 2025 Jan 2;8(1):e2454776. doi: 10.1001/jamanetworkopen.2024.54776.
2
Substance Use Treatment Utilization Among Individuals With Substance Use Disorders in the United States During the COVID-19 Pandemic: Findings on the Role of Polysubstance Use, Criminal Justice Involvement, and Mental Illness From the National Survey on Drug Use and Health.COVID-19大流行期间美国物质使用障碍患者的物质使用治疗利用情况:来自全国药物使用和健康调查的关于多物质使用、刑事司法参与和精神疾病作用的调查结果
Subst Use. 2024 Jun 12;18:29768357241259947. doi: 10.1177/29768357241259947. eCollection 2024 Jan-Dec.
3
Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999-2018.在阿片类药物泛滥期间,1999-2018 年美国白人和黑人的多种物质导致的死亡率趋势。
BMC Public Health. 2024 Jan 7;24(1):112. doi: 10.1186/s12889-023-17563-x.
4
Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics.农村基层医疗诊所中阿片类药物使用障碍患者共病物质使用障碍。
J Subst Use Addict Treat. 2024 Mar;158:209269. doi: 10.1016/j.josat.2023.209269. Epub 2023 Dec 12.
5
Prediction of opioid-related outcomes in a medicaid surgical population: Evidence to guide postoperative opiate therapy and monitoring.医疗补助手术人群中阿片类药物相关结局的预测:指导术后阿片类药物治疗和监测的证据。
PLoS Comput Biol. 2023 Aug 14;19(8):e1011376. doi: 10.1371/journal.pcbi.1011376. eCollection 2023 Aug.
6
Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.多物质使用障碍与医疗补助受益的阿片类药物使用障碍患者的治疗质量之间的关联。
J Subst Abuse Treat. 2023 Jan;144:108921. doi: 10.1016/j.jsat.2022.108921. Epub 2022 Oct 27.
7
Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York.纽约州纽约市医疗补助受助人的物质使用障碍护理绩效指标。
JAMA Health Forum. 2022 Jul 1;3(7):e221771. doi: 10.1001/jamahealthforum.2022.1771. eCollection 2022 Jul.
8
A national profile of substance use disorder among Medicaid enrollees on the autism spectrum or with intellectual disability.全国范围内的医疗补助受助人(自闭症谱系或智力残疾)物质使用障碍情况概况。
Disabil Health J. 2022 Jun;15(2S):101289. doi: 10.1016/j.dhjo.2022.101289. Epub 2022 Mar 7.